The effect of endostatin mediated by human mesenchymal stem cells on ovarian cancer cells in vitro

Journal of Cancer Research and Clinical Oncology

Volumn 136, Issue 6, 2010, Pages 873-881

  Jiang, Jing ^a   Chen, Wei ^b   Zhuang, Rujin ^a   Song, Tiefang ^a   Li, Peiling ^a  

^a HARBIN MEDICAL UNIVERSITY   (China)

^b THE SECOND AFFILIATED HOSPITAL OF HARBIN MEDICAL UNIVERSITY   (China)

Author keywords

Antiangiogenesis; Cancer; Endostatin; Gene therapy; Mesenchymal stem cell; Migration

Indexed keywords

ANGIOGENESIS INHIBITOR; ENDOSTATIN;

ADENOCARCINOMA; ADENOVIRUS; APOPTOSIS; ARTICLE; CELL PROLIFERATION; DRUG EFFECT; FEASIBILITY STUDY; FEMALE; FLOW CYTOMETRY; FLUORESCENT ANTIBODY TECHNIQUE; GENE THERAPY; GENETIC TRANSFECTION; GENETICS; HUMAN; MESENCHYMAL STEM CELL; METHODOLOGY; OVARY TUMOR; TUMOR CELL LINE; VASCULARIZATION; WESTERN BLOTTING;

ADENOCARCINOMA; ADENOVIRIDAE; ANGIOGENESIS INHIBITORS; APOPTOSIS; BLOTTING, WESTERN; CELL LINE, TUMOR; CELL PROLIFERATION; ENDOSTATINS; FEASIBILITY STUDIES; FEMALE; FLOW CYTOMETRY; FLUORESCENT ANTIBODY TECHNIQUE; GENE THERAPY; HUMANS; MESENCHYMAL STEM CELLS; OVARIAN NEOPLASMS; TRANSFECTION;

EID: 77951631775     PISSN: 01715216     EISSN: 14321335     Source Type: Journal    
DOI: 10.1007/s00432-009-0728-8     Document Type: Article

References (48)

1. Campagnoli C, Roberts IA, Kumar S, Bennett PR, Bellantuono I, Fisk NM (2001) IdentiWcation of mesenchymal stem/progenitor cells in human Wrst-trimester fetal blood, liver, and bone marrow. Blood 98:2396-2402
2. Ceradini DJ, Kulkarni AR, Callaghan MJ, Tepper OM, Bastidas N, Kleinman ME et al. (2004) Progenitor cell traYcking is regulated by hypoxic gradients through HIF-1 induction of SDF-1. Nat Med 10:858-864
3. Coutinho EL, Andrade LN, Chammas R et al. (2007) Anti-tumor eVect of endostatin mediated by retroviral gene transfer in mice bearing renal cell carcinoma. FASEB J 21(12):3153-3161
4. Dkhissi F, Lu H, Soria C et al. (2003) Endostatin exhibits a direct antitumor eVect in addition to its antiangiogenic activity in colon cancer cells. Hum Gene Ther 14(10):997-1008
5. Eder JP Jr, Supko JG, Clark JW et al. (2002) Phase I clinical trial of recombinant human endostatin administered as a short intravenous infusion repeated daily. J Clin Oncol 20:3772-3784
6. Folkman J (2002) Role of angiogenesis in tumor growth and metastasis. Semin Oncol 29(suppl 16):15-18
7. Folkman J (2004) Endogenous angiogenesis inhibitors. APMIS 112:496-507
8. Folkman J (2005) Antiangiogenesis in cancer therapy-endostatin and its mechanisms of action. Exp Cell Res 312:594-606
9. Folkman J (2006) Angiogenesis in cancer therapy-endostatin and its mechanisms of action. Exp Cell Res 312:594-607
10. Hall B, Dembinski J, Sasser AK, Studeny M, AndreeV M, Marini F (2007) Mesenchymal stem cells in cancer: tumor-associated Wbroblasts and cell-based delivery vehicles. Int J Hematol 86:8-16
11. Hanahan D, Weinberg RA (2000) The hallmarks of cancer. Cell 100:57-70
12. He GA, Xue G, Xiao L et al. (2005) Dynamic distribution and expression in vivo of human endostatin gene delivered by adenoviral vector. Life Sci 77:1331-1340
13. Herbst RS, Hess KR, Tran HT, Tseng JE, Mullani NA, Charnsangavej C et al. (2002) Phase I study of recombinant human endostatin in patients with advanced solid tumors. J Clin Oncol 20:3792-3803
14. Kaya M, Wada T, Nagoya S, Yamashita T (2007) Prevention of postoperative progression of pulmonary metastases in osteosarcoma by antiangiogenic therapy using endostatin. J Orthop Sci 12(6):562-567
15. Kikkawa F, Matsuzawa K, Arii Y, Kawai M, Kobayashi I, Nakashima N, Mizutani S (2000) Randomized trial of cisplatin and carboplatin versus cisplatin, vinblastine and bleomycin in ovarian cancer. Gynecol Oncol Investig 50:269-274
16. Kikuchi E, Menendez S, Ohori M et al. (2004) Inhibition of orthotopic human bladder tumor growth by lentiviral gene transfer of endostatin. Clin Cancer Res 10:1835-1842
17. Kirsch M, Weigel P, Pinzer T et al. (2005) Therapy of hematogenous melanoma brain metastasis with endostatin. Clin Cancer Res 11:1259-1267
18. Kisker O, Becker CM, Prox D et al. (2001) Continuous administration of endostatin by intraperitoneally implanted osmotic pump improves the eYcacy and potency of therapy in a mouse xenograft tumor model. Cancer Res 61:7669-7674
19. Kucia M, Reca R, Jala VR, Dawn B, Ratajczak J, Ratajczak MZ (2005) Bone marrow as a home of heterogenous populations of nonhematopoietic stem cells. Leukemia 19:1118-1127
20. Lee OK, Kuo TK, Chen WM, Lee KD, Hsieh SL, Chen TH (2004) Isolation of multipotent mesenchymal stem cells from umbilical cord blood. Blood 103:1669-1675
21. Li XP, Li CY, Li X et al. (2006) Inhibition of human nasopharyngeal carcinoma growth and metastasis in mice by adenovirus-associated virus-mediated expression of human endostatin. Mol Cancer Ther 5:1290-1298
22. Liby K, Neltner B, Mohamet L et al. (2003) Endostatin expression by MDA-MB-435 breast cancer cells eVectively inhibits tumor growth. Cancer Biol Ther 2:53-54
23. Marx J (2003) Angiogenesis: a boost for tumor starvation. Science 301:452-454
24. Matus S, Frank C, Marini RE (2002) Bone marrow-derived mesenchymal stem cells as vehicles for interferon-B delivery into tumors. Cancer Res 62:3603-3608
25. Nakamizo A, Marini F, Amano T, Khan A, Studeny M, Gumin J et al. (2005) Human bone marrow-derived mesenchymal stem cells in the treatment of gliomas. Cancer Res 65:3307-3318
26. Nyberg P, Xie L, Kalluri R (2005) Endogenous inhibitors of angiogenesis. Cancer Res 65:3967-3979
27. O'Reilly MS, Boehm T, Shing Y, Fukai N, Vasios G, Lane WS (1997) Endostatin: an endogenous inhibitor of angiogenesis and tumor growth. Cell 88:277-285
28. Ozols RF (2000) Optimum chemotherapy for ovarian cancer. Int J Gynecol Cancer 10:33-37
29. Pittenger MF, Mackay AM, Beck SC, Jaiswal RK, Douglas R, Mosca JD et al. (1999) Multilineage potential of adult human mesenchymal stem cells. Science 284:143-147
30. Prockop DJ, Gregory CA, Spees JL (2003) One strategy for cell and gene therapy: harnessing the power of adult stem cells to repair tissues. Proc Natl Acad Sci USA 100(Suppl 1):11917-11923
31. RaWi S, Lyden D (2003) Therapeutic stem and progenitor cell transplantation for organ vascularization and regeneration. Nat Med 9:702-712
32. Rosu-Myles M, Stewart E, Trowbridge J, Ito CY, Zandstra P, Bhatia M (2005) A unique population of bone marrow cells migrates to skeletal muscle via hepatocyte growth factor/c-met axis. J Cell Sci 118:4343-4352
33. Salvesen HB, Gulluoglu MG, Stefansson I, Akslen LA (2003) SigniWcance of CD 105 expression for tumour angiogenesis and prognosis in endometrial carcinomas. APMIS 111:1011-1018
34. Sebastian H, Annette W, Susanne L et al. (2008) Expression and secretion of endostatin in thyroid cancer. Ann Surg Oncol 15:3601-3608
35. Shih IeM, Kurman R (2004) Ovarian tumorigenesis: a proposed model based on morphological and molecular genetic analysis. Am J Pathol 164:1511-1518
36. Sorensen DR, Read TA (2002) Delivery of endostatin in experimental cancer therapy. Int J Exp Pathol 83:265-274
37. Studeny M, Marini FC, Dembinski JL, Zompetta C, Cabreira-Hansen M, Bekele BN et al. (2004) Mesenchymal stem cells: potential precursors for tumor stroma and targeted-delivery vehicles for anticancer agents. J Natl Cancer Inst 96:1593-1603
38. Subramanian IV, Gherbre R, Ramakrishnan S (2005) Adeno-associated virus-mediated delivery of mutant endostatin suppresses ovarian carcinoma growth in mice. Gene Ther 12:30-38
39. Subramanian IV, Bui Nguyen TM, Truskinovsky AM et al. (2006) Adeno-associated virus-mediated delivery of a mutant endostatin in combination with carboplatin treatment inhibits orthotopic growth of ovarian cancer and improves long-term survival. Cancer Res 66(8):4319-4328
40. Tatyana I, Diptiman C, Lisa K et al. (2007) EVects of sustained antiangiogenic therapy in multistage prostate cancer in TRAMP model. Cancer Res 67:5789-5797
41. Thulesius HO, Lindgren AC, Olsson HL, Hakansson A (2004) Diagnosis and prognosis of breast and ovarian cancer: a populationbased study of 234 women. Acta Oncol 43:175-181
42. Toma C, Pittenger MF, Cahill KS, Byrne BJ, Kessler PD (2002) Human mesenchymal stem cells diVerentiate to a cardiomyocyte phenotype in the adult murine heart. Circulation 105:93-98
43. Trimble EL (2006) Concluding remarks: optimal treatment for women with ovarian cancer. Semin Oncol 33(Suppl 12):S25-S26
44. suboi S, Nouso K, Tomono Y et al. (2004) Anti-endostatin monoclonal antibody enhances growth of human hepatocellular carcinoma cells by inhibiting activity of endostatin secreted by transplantes cells in nude mice. Int J Oncol 25:1267-1271
45. Wang L, Li Y, Chen X, Chen J, Gautam SC, Xu Y et al. (2002) MCP-1, MIP-1, IL-8 and ischemic cerebral tissue enhance human bone marrow stromal cell migration in interface culture. Hematology 7:113-117
46. Wickstrom SA, Alitalo K, Keski-Oja J (2005) Endostatin signaling and regulation of endothelial cell-matrix interactions. Adv Cancer Res 94:197-229
47. Woodbury D, Schwarz EJ, Prockop DJ, Black IB (2000) Adult rat and human bone marrow stromal cells diVerentiate into neurons. J Neurosci Res 61:364-370
48. Yang W, Li XY (2005) Anti-tumor eVect of pEgr-interferon-gammaendostatin gene-radiotherapy in mice bearing Lewis lung carcinoma and its mechanism. Chin Med J 118:296-301